Key Metrics 
Check Before You Invest 
10 Yrs X-Ray 
Valuation 
Analyst Note 
Qtr. Results 
Financials 
News 
About
Amanta Healthcare Ltd (AMANTA)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 544502 NSE: AMANTA Pharmaceuticals & Drugs | Small Cap | Amanta Healthcare Share Price
₹186 0.00 (0.00%)
As on 25-Sep'26 16:59
Amanta Healthcare Ltd (AMANTA)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 544502 NSE: AMANTA Pharmaceuticals & Drugs | Small Cap | Amanta Healthcare Share Price
₹186 0.00 (0.00%)
As on 25-Sep'26 16:59
Key Metrics
Valuation Multiples
Market Cap
₹722 Cr.
Current Price
₹186
52-Week Low / High
₹93 / 207
TTM EPS
-
TTM Sales
-
Book Value per Share
-
P/E Ratio
Industry PE
54.9
Price to Book (P/B)
Price to Sales (P/S)
EV/EBITDA
Dividend Yield
0%
Profitability Efficiency
Return on Equity (ROE)
%
Return on Capital Employed (ROCE)
%
Return on Assets (ROA)
%
Operating Profit Margin
0%
Net Profit Margin
-%
Gross Profit Margin
0%
Growth Momentum
1-yr vs 3-yr growth
1-yr vs 3-yr growth
Sales Growth (1 Year)
Improving versus 3-year growth rate
4.72%
Operating Profit Growth (1 Year)
-
-
Net Profit Growth (1 Year)
-
-
Asset Quality
Promoter Holding
63.80%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
-
Equity
₹38.8 Cr.
Face Value
₹10
All Time Low / High
₹93.10 / 206.65
Check Before You Invest
Quality
Not GoodValuation
OvervaluedCheck Valuation charts
Price Trend
Semi Strong
Is Amanta Healthcare Ltd a good quality company?
Amanta Healthcare Ltd is a weak quality company, based on a inconsistent multi-year financial track record.
This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.
We have analysed the performance of the company on the following:
-
How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
-
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
-
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.
How does Amanta Healthcare Ltd performance compare with that of its Peers?
Revenue growth of Amanta Healthcare Ltd vs industry peers?
Amanta Healthcare Ltd revenue CAGR is %, compared to the industry median CAGR of 0.00%, indicating stable growth and maintaining its market share.
Promoter shareholding and pledge status of Amanta Healthcare Ltd?
Promoters hold 63.80% of the Amanta Healthcare Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Stock return of Amanta Healthcare Ltd over the last decade?
Over the last 1 year(s), the stock has delivered a CAGR of 34.59% based on the current price.
10 Year X-Ray :
Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year endData adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
What is a Financial Track Record? How to read this chart in order to understand the data present here?
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Amanta Healthcare Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good
Value Creation ⓘ
| Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % ⓘ | 12.7% | 10.3% | 8.4% | 8.3% | 8.9% | 40% | 13.4% | 14.2% | 15.2% | 11.2% | - |
| Value Creation Index ⓘ | -0.1 | -0.3 | -0.4 | -0.4 | -0.4 | 1.9 | 0.0 | 0.0 | 0.1 | NA | - |
Growth Parameters ⓘ |
|||||||||||
| Sales ⓘ | 211 | 192 | 185 | 184 | 171 | 225 | 259 | 280 | 275 | 288 | 291 |
| Sales YoY Gr. | - | -9.3% | -3.5% | -0.3% | -7.1% | 31.6% | 14.9% | 8.2% | -2% | 4.7% | - |
| Adj EPS ⓘ | 6.3 | 3.9 | -7.1 | -7.5 | -8.2 | 2.1 | -1.2 | 1.5 | 3.6 | 4.1 | 3.8 |
| YoY Gr. | - | -38.6% | -282.5% | NA | NA | NA | -156.6% | NA | 143% | 13.3% | - |
| BVPS (₹) ⓘ | 46.3 | 25 | 17.9 | 10.9 | 2.7 | 24.2 | 23.4 | 24.7 | 33.4 | 56.7 | 57.6 |
| Adj Net Profit ⓘ | 23.2 | 10.3 | -19 | -20 | -22.1 | 5.7 | -3.2 | 4 | 10.4 | 15.9 | 15 |
| Cash Flow from Ops. ⓘ | 40.2 | 25.2 | 32.2 | 37.9 | 33.4 | 63.5 | 42.6 | 58.1 | 46.6 | 48.5 | - |
| Debt/CF from Ops. ⓘ | 2.2 | 10.1 | 7.7 | 6.1 | 7 | 3.5 | 5.1 | 3.5 | 4.2 | 4.8 | - |
CAGR ⓘ
| 9 Years | 5 Years | 3 Years | 1 Years | |||||
|---|---|---|---|---|---|---|---|---|
| Sales ⓘ | 3.5% | 10.9% | 3.6% | 4.7% | ||||
| Adj EPS ⓘ | -4.7% | NA | NA | 13.3% | ||||
| BVPSⓘ | 2.3% | 83.7% | 34.3% | 69.6% | ||||
| Share Price | - | - | - | 34.6% | ||||
Key Financial Parameters ⓘ
| Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity % ⓘ | 11.4 | 7.3 | -33.1 | -52 | -121.4 | 15.7 | -5.1 | 6.2 | 12.8 | 10.1 | 6.6 |
| Op. Profit Mgn % ⓘ | 24.4 | 24.2 | 22.1 | 20.3 | 22.4 | 23.8 | 19.8 | 20.7 | 21.8 | 20.8 | 20.4 |
| Net Profit Mgn % ⓘ | 11 | 5.4 | -10.3 | -10.9 | -12.9 | 2.5 | -1.3 | 1.4 | 3.8 | 5.5 | 5 |
| Debt to Equity ⓘ | 0.4 | 3.8 | 5.2 | 7.9 | 32.3 | 3.4 | 3.4 | 3.1 | 2 | 1.1 | - |
| Working Cap Days ⓘ | 194 | 238 | 269 | 277 | 296 | 215 | 179 | 162 | 185 | 210 | 147 |
| Cash Conv. Cycle ⓘ | 59 | 91 | 114 | 133 | 160 | 120 | 103 | 97 | 106 | 102 | 68 |
Valuation of Amanta Healthcare - Consolidated
Analyst's Notes
No data found!
Management X-Ray
Shareholding Pattern
Promoter's Holding & Share Pledging
| Pledged * | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
* Pledged shares as % of Promoter's holding (%)
Financials
No data found!
No data found!
No data found!
No data found!
Top 5 Mutual Funds Holding
Last Visited Stocks
Announcements
Amanta Healthcare Ltd FAQs
The current trading price of Amanta Healthcare on 25-Sep-2026 16:59 is ₹186.0.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 24-Sep-2026 the market cap of Amanta Healthcare stood at ₹722.2 Cr
The latest P/E ratio of Amanta Healthcare as of 24-Sep-2026 is 49.21.
The latest P/B ratio of Amanta Healthcare as of 24-Sep-2026 is 3.23.
The 52-week high of Amanta Healthcare is ₹206.7 and the 52-week low is ₹93.10.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Amanta Healthcare is ₹291 ( Cr.) .
Past 10 year’s financial track record analysis by Moneyworks4me indicates that Amanta Healthcare Ltd is a below average quality company.
The key valuation ratios of Amanta Healthcare Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.
The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of Amanta Healthcare Ltd is likely to Rise-somewhat in the short term. However, please check the rating on Quality and Valuation before investing.
About Amanta Healthcare Ltd
Marck Biosciences Limited was originally incorporated as Marck Parenterals (India) Limited on December 1994. Subsequently, the name of the company was changed to Marck Biosciences Limited on November 2, 2005. The company’s registered office is located at 5th Floor, Heritage, Nr. Gujarat Vidhyapith, Off. Ashram Road,Ahmedabad – 380 014, Gujarat, India. It manufacture and market around 80 therapeutic and non therapeutic products. Its therapeutic product groups comprise of Fluid Therapy, Injections, Eye Care and Respiratory Care. Its non therapeutic product group comprises of Medical Devices. Medical devices would predominantly be of products such as, Lens cleaning solutions, Eye & wound Irrigation, Eye wash Solution and First aid Solution, for which the company has obtained ‘CE’ mark.
Business Profile:
The company is a sterile liquid pharmaceutical company headquartered at Ahmedabad, Gujarat, India. Its scope of activities includes formulation and development, manufacturing and marketing in India and approximately 77 countries across 6 continents. It manufacture and market around 80 therapeutic and non therapeutic products. Its therapeutic product groups comprise of fluid therapy, injections, eye care and respiratory care. The non therapeutic product group comprises of medical devices. medical devices would predominantly be of products such as, lens cleaning solutions, eye and wound irrigation, eye wash solution and first aid Solution, for which the company has obtained ‘CE’ mark. Its manufacturing facilities comprises of five Aseptic Blow Fill Seal (ABFS) manufacturing lines and one Aspectic Conventional Plastic Bottle Filling line. It is one of the versatile manufacturer in BFS space, wherein it offer different closure systems, such as nipple head, twist-off, leur-lock & screw types and container fill-volume ranging from 2ml to 1000 ml.
Product Segment:
- Fluid Therapy Products
- Formulations
- Medical Devices
Promoter Group Companies :
- Milcent Appliances Private Limited (MAPL)
- American Mannequin INC
Group entities:
- Marck Remedies Limited (MRL)
- Mangneto Induction Pvt Limited
You have 49 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
